CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Galectin Therapeutics Incorporated Company Snapshot


Sales Analysis.
   
   
 
  Stock Performance Chart for Galectin Therapeutics Incorporated
 
  Stock Data: Recent Stock Performance:
  Current Price (7/31/2020): 2.61
(Figures in U.S. Dollars)
1 Week -1.9%   13 Weeks -10.6%  
4 Weeks -3.3%   52 Weeks -22.3%  
 
Galectin Therapeutics Incorporated Key Data:
  Ticker: GALT Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2001 Sales
(Year Ending Jan 2002).
Employees: 7
  Currency: U.S. Dollars Market Cap: 148,846,235
  Fiscal Yr Ends: December Shares Outstanding: 57,029,209
  Share Type: Common Closely Held Shares: 16,162,196
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.